科研之友
微信
新浪微博
Facebook
分享链接
摘要
Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-dependent transcription factor involved in many aspects of metabolism, immune response, and development. Totalbody deletion of the two Pparg alleles provoked generalized lipoatrophy along with severe type 2 diabetes. Herein, we explore the appearance and development of structural and functional alterations of the kidney, comparing Pparg null-mice to their littermate controls (carrying Pparg floxed alleles). We show that renal hypertrophy and functional alterations with increased glucosuria and albuminuria are already present in 3 weeks-old Pparg null-mice. Renal insufficiency with decreased creatinine clearance progress at 7 weeks of age, with the advance of the type 2 diabetes. At 52 weeks of age, these alterations are accompanied by signs of fibrosis and mesangial expansion. More intriguingly, aged Pparg null-mice concomitantly present an anti-phospholipid syndrome (APS), characterized by the late appearance of microthrombi and a mesangioproliferative pattern of glomerular injury, associated with significant plasmatic levels of anti-beta(2)-glycoprotein1 antibodies and renal deposition of IgG, IgM, and C3. Thus, in line with the role of PPAR gamma in metabolic homeostasis, Pparg nullmice first represent a potent model for studying the initiation and the development of diabetic nephropathy. Second, and in relation with the important PPAR gamma activity in inflammation and in immune system, these mice also highlight a new role for PPAR gamma signaling in the promotion of APS, a syndrome whose pathogenesis is poorly known and whose current treatment is limited to prevention of thrombosis events.
- 出版日期2017-2-9
